🔗 Share this article

Chancellor Reeves has revealed she is planning "targeted action to tackle cost of living challenges" in the upcoming financial statement.

Speaking to the BBC, she emphasized that curbing price rises is a joint task of both the administration and the central bank.

The United Kingdom's inflation rate is expected to be the highest among the Group of Seven industrialized countries this year and next.

Potential Utility Cost Measures

Reports indicate the administration could intervene to reduce energy bills, for example by reducing the present 5% rate of value-added tax applied on energy.

A further possibility is to cut some of the government charges currently included in household expenses.

Budgetary Limitations and Analyst Predictions

The administration will receive the latest report from the official forecaster, the OBR, on the start of the week, which will show how much room there is for these actions.

The view from the majority of experts is that Reeves will have to introduce tax rises or spending cuts in order to fulfill her declared fiscal targets.

Earlier on Thursday, analysis showed there was a £22 billion deficit for the chancellor to resolve, which is at the lower end of expectations.

"There's a joint task between the central bank and the administration to bear down further on some of the causes of inflation," the Chancellor informed reporters in the US capital, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and Global Concerns

While much of the attention has been on probable tax increases, the Treasury chief said the latest information from the OBR had not altered her pledge to manifesto promises not to increase rates on income tax, VAT or social security contributions.

She attributed an "uncertain world" with increasing geopolitical and commercial issues for the Budget tax moves, likely to be targeted on those "most able to pay."

International Economic Disputes

Referring to concerns about the United Kingdom's trade ties with China she said: "Our security interests always come first."

Last week's announcement by China to tighten export controls on rare earths and other materials that are key for advanced tech manufacturing led US President the US President to threaten an further 100% tariff on imports from the Asian country, raising the prospect of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary called China's decision "commercial pressure" and "a global supply chain power grab."

Inquired about accepting the US offer to join its conflict with China, the Chancellor said she was "very concerned" by Chinese measures and encouraged the Chinese government "not to put up barriers and limit trade."

She said the decision was "bad for the international commerce and generates additional challenges."

"I believe there are fields where we need to address China, but there are also important prospects to sell into China's economy, including banking sector and other areas of the economy. We've got to get that equilibrium appropriate."

The chancellor also confirmed she was cooperating with G7 counterparts "on our own critical minerals approach, so that we are more independent."

Health Service Drug Costs and Funding

Reeves also admitted that the cost the NHS spends on medicines could rise as a consequence of current talks with the US government and its drugs companies, in return for lower tariffs and funding.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or canceling projects in the UK, with some attributing the modest returns they are getting.

Recently, the government science advisor said the cost the NHS pays for drugs would must rise to prevent firms and pharmaceutical investment leaving the UK.

The Chancellor stated to media: "We have seen due to the payment system, that clinical trials, innovative medicines have not been provided in the United Kingdom in the way that they are in other continental states."

"The objective is to guarantee that individuals getting care from the National Health Service are able to obtain the finest life-saving drugs in the globe. And so we are looking at these issues, and... seeking to obtain more investment into Britain."